Skip to main content
Equibles

STIFEL FINANCIAL CORP

Position in LGND — Ligand Pharmaceuticals Inc

CIK 720672 ST. LOUIS, MO
Back to LGND Full portfolio

Position in LGND

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$11,642,541
+$5,050,698 QoQ
Shares Held
36,833
+11.6% QoQ
Ownership
0.185%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#80
of 415 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in LGND Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STIFEL FINANCIAL CORP holds $538,947,950 across 105 Biotechnology names. LGND ranks #10 (2.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BHVN
Biohaven Ltd.
 9,941,165 $147,924,534
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 162,151 $80,545,262
3 MANE
Veradermics, Inc
 294,117 $36,158,743
4 JAZZ
Jazz Pharmaceuticals plc
 139,491 $33,613,146
5 REGN
Regeneron Pharmaceuticals, Inc.
 46,378 $28,918,535
6 OMER
Omeros Corp
 1,836,925 $17,469,155
7 NTLA
Intellia Therapeutics, Inc.
 1,014,387 $17,163,427
8 IONS
Ionis Pharmaceuticals Inc
 202,983 $16,094,521

All Filings in LGND

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $11,642,541 36,833
2026-03-31 $6,591,843 33,017
2025-12-31 $3,539,766 18,722
2025-09-30 $3,633,494 20,512
2025-06-30 $2,026,914 17,830
2025-03-31 $1,865,182 17,740
2024-12-31 $1,801,512 16,813
2024-09-30 $1,596,333 15,949
2024-06-30 $1,151,075 13,661
2024-03-31 $581,655 7,957
2023-12-31 $513,223 7,186
2023-09-30 $442,388 7,383
2023-06-30 $547,814 7,598
2023-03-31 $324,398 4,410
2020-12-31 $734,238 7,383
2020-09-30 $756,363 7,935
2020-06-30 $812,030 7,260
2020-03-31 $317,640 4,368